QLGN News and Press, Qualigen Therapeutics Inc. From 09/17/20

CARLSBAD, Calif. , Sept. 17, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN) announces its and the University of Louisville's joint filing of a United States provisional patent application, entitled "Methods of inhibiting or treating coronavirus infection, and method...

CARLSBAD, Calif. , Aug. 31, 2020 /PRNewswire/ --  Qualigen Therapeutics, Inc. (Nasdaq: QLGN) announced today it has signed a contract with IRISYS LLC for the production of AS1411, Qualigen's lead drug candidate for the treatment of viral diseases including COVID-19. Preclinica...

CARLSBAD, Calif. , Aug. 28, 2020 /PRNewswire/ --  Qualigen Therapeutics, Inc. (Nasdaq: QLGN) announced today the addition of pharmaceutical executive Amy Broidrick to the company's Board of Directors.  Ms. Broidrick's background includes key roles in the successful worl...

Alliance Global Partners upgrades Qualigen ( QLGN +4.0% ) to Buy with a $10 (107% upside) price target. In a note, analyst James Molloy regards the company as a "compelling opportunity" in cancer detection and treatment. More news on: Qualigen Therapeutics, Inc., Healthcare stocks news, ...

The USPTO has issued a new patent to Qualigen Therapeutics (NASDAQ: QLGN ) entitled "Devices and Methods for On-Line Whole Blood Treatment" regarding Company's Selective Target Antigen Removal System (STARS) technology. More news on: Qualigen Therapeutics, Inc., Healthcare stocks news,...

CARLSBAD, Calif. , Aug. 20, 2020 /PRNewswire/ --  Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) announced today that the United States Patent and Trademark Office has issued patent No. 10,744,257 entitled "Devices and Methods for On-Line Whole Blood Treatment"...

For  FQ1 , Qualigen Therapeutics ( QLGN -5.3% ) reported revenue of $0.9M (-40.4% Y/Y), led by a decrease in patient visits to physician offices, clinics and small hospitals amid pandemic, which reduced the number of FastPack tests performed. More news on: Qualigen Therapeutics, I...

Qualigen Therapeutics, Inc. (QLGN) Q1 2021 Results Conference Call August 18, 2020 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Michael Poirier - Chairman, President and CEO Christopher Lotz - Chief Financial Officer Conference Call Participants ...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

Qualigen Therapeutics (NASDAQ: QLGN ) : FQ1 GAAP EPS of -$2.12. More news on: Qualigen Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...